Discover how engineers will develop and validate projects using next-generation manufacturing systems, advances in bioprocessing and streamlined compliance programs.
What you need to know before you go.
New Speaker Announced David Doleski, Acting Director of the Division of Good Manufacturing Practice Assessment in the Office of Compliance, Center for Drug Evaluation and Research (CDER), FDA joins as a plenary speaker.
Plenary Speaker Confirmed! Dr. Oliver Smithies, University of North Carolina School of Medicine, Nobel Laureate